<html>
<head>PUBMED IDs for SAMD9L</head>
<body bgcolor='#C5F0F2'><h1>SAMD9L</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19531577/'>Longitudinal system-based analysis of transcriptional responses to type I interferons.</a> January 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21412262/'>The Samd9L gene: transcriptional regulation and tissue-specific expression in mouse development.</a> August 31  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22716256/'>Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis.</a> December 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23019126/'>ΔNp63α represses anti-proliferative genes via H2A.Z deposition.</a> December 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23758988/'>Evolution and divergence of the mammalian SAMD9/SAMD9L gene family.</a> June 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24029230/'>Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25076857/'>SAMD9L inactivation promotes cell proliferation via facilitating G1-S transition in hepatitis B virus-associated hepatocellular carcinoma.</a> March 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25327574/'>Identification of potential genomic biomarkers for Sjögren's syndrome using data pooling of gene expression microarrays.</a> March 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25327569/'>Stable phenotype of B-cell subsets following cryopreservation and thawing of normal human lymphocytes stored in a tissue biobank.</a> August 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25543507/'>[Significance of chromosome 7 abnormalities in myeloid malignancies].</a> April 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27259050/'>Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.</a> May 11  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28202457/'>Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.</a> February 17  2017<br></body></html>
